Professor | Tao Meng | Asia Growth Partners

Name	Tao Meng
Contact Information	tmeng@sibs.ac.cn
Language ability	Chinese, English
Province	Shanghai

Name

Tao Meng

Contact Information

tmeng@sibs.ac.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Medical School
Academic Background & Achievements	2002-08--2007-05 Ph.D. in Science: Shanghai Institute of Materia Medica, Chinese Academy of Sciences 1996-09--2000-05 Bachelor's in Science: School of Pharmacy, Fudan University
Work Experience	2015-11~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Researcher 2008-10~2009-10 - University of Bern, Switzerland - Postdoctoral Researcher 2000-07~2015-10 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Research Intern, Assistant Researcher, Associate Researcher

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Medical School

Academic Background & Achievements

2002-08--2007-05 Ph.D. in Science: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
1996-09--2000-05 Bachelor's in Science: School of Pharmacy, Fudan University

Work Experience

2015-11~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Researcher
2008-10~2009-10 - University of Bern, Switzerland - Postdoctoral Researcher
2000-07~2015-10 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Research Intern, Assistant Researcher, Associate Researcher

Areas of Focus	Targeted Anti-tumor Drug Research Novel Antibody-Drug Conjugates Research
Publications	Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer., Oncotarget, 2016 Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents, Eur. J. Med. Chem., 2016 Ga(OTf)(3)-promoted synthesis of functionalized 2-carbonyl-imidazo[1,2-a]pyridines derived from ethyl alpha-benzotriazolyl-alpha-morpholinoacetate., Rsc Adv, 2015 Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90, J. Med. Chem., 2014 An efficient synthesis of novel dibenzoxdiazepine-fused heterocycles through a multicomponent reaction, Rsc Adv., 2014 Synthesis and biological evaluation of 6H-pyrido[2 ',1 ':2,3] imidazo[4,5-c] isoquinolin-5(6H)-ones as antimitotic agents and inhibitors of tubulin polymerization, Bioorgan Med Chem, 2014

Areas of Focus

Targeted Anti-tumor Drug Research
Novel Antibody-Drug Conjugates Research

Publications

Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer., Oncotarget, 2016
Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents, Eur. J. Med. Chem., 2016
Ga(OTf)(3)-promoted synthesis of functionalized 2-carbonyl-imidazo[1,2-a]pyridines derived from ethyl alpha-benzotriazolyl-alpha-morpholinoacetate., Rsc Adv, 2015
Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90, J. Med. Chem., 2014
An efficient synthesis of novel dibenzoxdiazepine-fused heterocycles through a multicomponent reaction, Rsc Adv., 2014
Synthesis and biological evaluation of 6H-pyrido[2 ',1 ':2,3] imidazo[4,5-c] isoquinolin-5(6H)-ones as antimitotic agents and inhibitors of tubulin polymerization, Bioorgan Med Chem, 2014

Targeted Therapy Anti-Tumor Drug Research Antibody-Drug Conjugates Cancer Treatment Pharmacology Chemotherapy Biotechnology Molecular Biology Oncology

Kui Hong - Wuhan University

Wenhu Duan - University of Chinese Academy of Sciences

Yi Li - University of Chinese Academy of Sciences

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us